Halozyme Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.

CEO

Helen I. Torley

CEOHelen I. Torley

Employees

350

Employees350

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

350

Employees350

HALO Key Statistics

Market cap

7.65B

Market cap7.65B

Price-Earnings ratio

18.37

Price-Earnings ratio18.37

Dividend yield

—

Dividend yield—

Average volume

1.77M

Average volume1.77M

High today

$63.14

High today$63.14

Low today

$60.63

Low today$60.63

Open price

$62.00

Open price$62.00

Volume

1.88M

Volume1.88M

52 Week high

$66.00

52 Week high$66.00

52 Week low

$37.73

52 Week low$37.73

HALO News

Simply Wall St 6d

Is Now The Time To Put Halozyme Therapeutics On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, an...

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

37.5%

Sell